Elucid (Series D)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
September 3, 2026
Vertical
Medical Technology
Funding URL
View Funding Page
Funding Amount
$55,000,000
Company Info
Traction
Elucid has raised approximately $185 million in total funding to date and has a growing syndicate of publicly traded partners.
Organizations Involved
large medtech company, Patient Square Capital
Market
Cardiovascular Diagnostics
Location
Boston, MA, USA
Coinvestors
IAG Capital Partners, Elevage Medical Technologies
Company Description

Elucid is a medical technology company that develops AI to see invisible features of cardiovascular risk. The company is dedicated to developing a clinical platform to help physicians deliver CCTA-guided personalized care by providing a more precise view of atherosclerosis, the root cause of cardiovascular disease.

Links
Website
Back to HomeBack to Medical Technology DealsView Funding Announcement